We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
The patient is a 12 year old spayed female Miniature Pinscher with increased liver enzyme levels in the past two blood screens. The dog has a previous history of hematuria.
The patient is a 12 year old spayed female Miniature Pinscher with increased liver enzyme levels in the past two blood screens. The dog has a previous history of hematuria.
Dorsal bladder tumor, appears resectable. Alternatively, ultrasound-guided laser ablation could be utilized in this case and may be ideal if micro-metastasis is noted within the pelvic urethra. If any metastasis were visualized by the scope, they could be treated at the time. Otherwise, dorsal partial cystectomy of the bladder wall would be recommended. Unfortunately, the surgeon will have minimal tissue with which to work.
The urinary bladder in this patient contained a dorsal wall mass that measured 2.18 cm at the base of the mass and 1.56 cm at the mid-body of the mass. This mass encroached upon the ureters and ureteral papilla, but did not obstruct the flow of urine. The mass extended caudally approximately 0.8 cm from the right ureteral papilla. This may prove to be resectable. Significant vascularity was noted with focal areas of mineralization, which is strongly suggestive of transitional cell carcinoma.
No further outcome at this time.
Hematuria – renal disease (neoplasia, reno/ureterolith, pyelonephritis, telangiectasia), bladder disease (neoplasia, cystitis, urolith). Elevated liver enzymes – vacuolar hepatopathy, reactive hepatopathy, nodular regeneration, neoplasia, toxins, infectious (bacterial/fungal), chronic-active hepatitis.
Histopathology revealed transitional cell carcinoma.
